America’s Health Insurance Plans today released findings from a study assessing health insurance claims from 2009 to 2013 on six recommendations from the Centers for Disease Control and Prevention’s Guideline for Prescribing Opioids for Chronic Pain. According to AHIP, the vast majority of opioid prescriptions for chronic pain were for immediate-release opioids, consistent with CDC recommendations, but certain other measures could be improved. For example, about one-quarter of opioid prescriptions were above the CDC-recommended morphine milligram equivalent dosage, the organization said. The study methodology has been shared with insurance providers nationwide, who may apply it to measure their own opioid prevention and management efforts.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Dec. 19 issued two proposed rules for implementing alternative drug pricing models. The first proposed…
Headline
The White House announced Dec. 19 that it reached most-favored-nation deals with nine pharmaceutical companies, aligning their drug prices with the lowest paid…
Headline
The House Dec. 17 passed the Lower Health Care Premiums for All Americans Act (H.R. 6703), legislation to expand association health plans, increase…
Headline
The AHA Dec. 17 urged Elevance Health, which is the parent company of the Anthem brand of health plans, to rescind Anthem’s nonparticipating provider…
Headline
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug Pricing Program.  “When…
Headline
The American Medical Association Dec. 16 released its latest annual report on health insurance competition, finding that 97% of commercial markets were highly…